Quest Diagnostics Incorporated operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Quest Diagnostics Incorporated with three other
pharmaceutical manufacturers in North America:
sales of $4.89 billion
of which 50%
Valeant Pharmaceuticals International Inc
(12.78 billion Canadian Dollars [US$9.57 billion]
of which 48%
was Bausch + Lomb / International segment), and
Laboratory Corporation of America Holdings
of which 70%
was LCD- net revenue).
During the year ended December of 2016, sales at
Quest Diagnostics Incorporated were $7.52 billion.
a very small
increase of 0.3%
versus 2015, when the company's sales were $7.49 billion.
This was the third consecutive year of growth at Quest Diagnostics Incorporated.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Quest Diagnostics Incorporated had sales
of $7.51 billion.
Sales of Dis Business saw an increase
that was more than double the company's growth rate: sales were up
2.5% in 2016, from
$6.97 billion to $7.14 billion.
Not all segments of Quest Diagnostics Incorporated experienced an increase in sales in 2016:
sales of Other Operating Segments fell 28.6% to $377.00 million.